F2‐03‐02: OPTIMIZING COGNITIVE OUTCOMES FOR BIOMARKER POSITIVE INDIVIDUALS AT DIFFERENT CLINICAL STAGES OF ALZHEIMER'S DISEASE ACCORDING TO THE NIA‐AA RESEARCH FRAMEWORK. (1st July 2019)